跳至主要内容
临床试验/TCTR20230830001
TCTR20230830001已完成2 期

Effectiveness of a Program to Slow the Progression of CKD among T2DM Patients with HT and CKD 3 in the Community: A Randomized Controlled Trial

Praboromarajchanok Institute, Thailand.0 个研究点目标入组 76 人开始时间: 2023年8月30日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
76

研究概览

简要总结

The results showed that after the experiment, the experimental group had significantly higher mean scores in terms of knowledge, perceived benefits, perceived severity, self-efficacy, and behaviors to slow the progression of kidney disease than the control group . Further, the experimental group had significantly better clinical outcomes (SBP, DBP, eGFR, BUN, creatinine, albuminuria, FBS, and HbA1c) than the control group.

研究设计

研究类型
Interventional

入排标准

年龄范围
40 Years 至 70 Years(—)
性别
All

入选标准

  • 1. patients with diabetes and hypertension with CKD 3 complication
  • 2. aged 40 to70 years,
  • 3. blood pressure > 140/90 mmHg at least once in the last six months
  • 4. HbA1C > 7% in the last six months
  • 5. able to communicate, read, and write in Thai
  • 6. lived with their family
  • 7. no complications or severe illnesses during the study that might have caused any obstacle to activity participation.

排除标准

  • 1.Need to be relocated away from Samutprakarn province during the study.
  • 2.Request to be withdrawn from the study.

研究者

发起方
Praboromarajchanok Institute, Thailand.

相似试验